Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis

BACKGROUND: PD-1/PD-L1 inhibitors have been implicated as potentially effective anti-cancer therapies. Some clinical randomized controlled trials (RCTs) have been completed for a variety of PD-1/PD-L1 inhibitors to treat various malignancies, and more RCTs are still under way. We carried out this sy...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Wang, Xiaohui, Bao, Zhengqiang, Zhang, Xiaoju, Li, Fei, Lai, Tianwen, Cao, Chao, Chen, Zhihua, Li, Wen, Shen, Huahao, Ying, Songmin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2017
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601788/
https://ncbi.nlm.nih.gov/pubmed/28938692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18316
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller